Asko Therapeutics, Inc.

Ann Arbor, MI

UEI
HXZAWBGUS6X6
CAGE
Not on record
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Woman Owned Small Business
  • Woman Owned Business
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
Center for Education of Women, 330 E Liberty St, Ann Arbor, MI 48104, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Novel injectable implants for long-term local controlled release of therapeutic monoclonal antibodies R43GM159467 National Institute of General Medical Sciences (NIH) $700,054
Paradigm-changing, versatile, scalable and cost-effective technology for monthly injections of peptide drugs R43GM157830 National Institute of General Medical Sciences (NIH) $350,027

Quick answers

Is Asko Therapeutics, Inc. registered in SAM.gov?

Yes. Asko Therapeutics, Inc.'s SAM.gov registration is active through December 29, 2026.

What is Asko Therapeutics, Inc.'s most recent federal award?

Asko Therapeutics, Inc.'s most recent federal grant award is Novel injectable implants for long-term local controlled release of therapeutic monoclonal antibodies (R43GM159467), from National Institute of General Medical Sciences (NIH), on August 1, 2025.

On GovTribe

See Asko Therapeutics, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login